2025, Bipolar disorder and Genetics and mental health

Eyes, Ears, and Emotion: Techniques to Tackle Diagnosing Bipolar Disorder

Psychiatric Times

JULY 14, 2025

Emerging research on RNA biomarkers, AI applications, and genetic mutations shows promise for developing new diagnostic tools for bipolar disorder. Non-pharmacological approaches and combination therapies are emphasized in treatment, with recent FDA approvals for new medications targeting bipolar symptoms.

Bipolar disorder

Bipolar disorder Genetics and mental health Sleep and mental health Eating disorders

The Psychiatric Pipeline in Review: Quarter 2, 2025

Psychiatric Times

JULY 7, 2025

The second quarter of 2025 saw some huge successes and fails in the psychiatric treatment pipeline. What percentage of 2025 Q2 psychiatric pipeline news was positive vs negative? Learn more in this exclusive article.

Pharmaceuticals

Pharmaceuticals Sleep and mental health Genetics and mental health Technology

FDA Requires New Label Warning of Weight Loss Risk in Pediatric Patients Taking Extended-Release Stimulants for ADHD

Psychiatric Times

JULY 1, 2025

SHOW MORE The FDA will update ADHD medication labels, warning of weight loss risks in children under 6, urging careful monitoring by health care professionals. Healthcare professionals should monitor weight and growth in young patients on these medications and consider alternative treatments if adverse effects occur.

Genetics and mental health

Genetics and mental health Bipolar disorder Sleep and mental health Aging and mental health

NRx Pharmaceuticals Applies for FDA National Priority Voucher for Intravenous Ketamine (NRX-100)

Psychiatric Times

JUNE 23, 2025

NRx is targeting suicidal depression and PTSD with NRX-100, anticipating an FDA decision by the end of 2025. The CNPV program, introduced by FDA Commissioner Marty Makary, aims to reduce review times to 1-2 months for eligible applications.

Pharmaceuticals

Pharmaceuticals Bipolar disorder Genetics and mental health Manufacturing

Risk Factors for ADHD

Psychiatric Times

JUNE 23, 2025

Overview of Attention Deficit/Hyperactivity Disorder EP: 2. Role of Pediatricians in Diagnosing ADHD ADHD risk factors encompass both genetic and environmental components that significantly impact child development. Risk Factors for ADHD EP: 7.

Genetics and mental health

Genetics and mental health Bipolar disorder Nutrition and mood Sleep and mental health

Nonstimulant Therapies for ADHD

Psychiatric Times

JUNE 30, 2025

Both medications carry important safety considerations including potential for increased suicidal ideation, requiring careful monitoring and education about distinguishing medication-related intrusive thoughts from situational mental health concerns.

Genetics and mental health

Genetics and mental health Bipolar disorder Neurotransmitters and mental health Sleep and mental health

ADHD Treatment Options

Psychiatric Times

JUNE 30, 2025

Related Videos Related Content Advertisement June 17th 2025 ADHD With Bipolar Disorder: Genetics, Diagnosis, and New Thinking on Treatment David N. Subscribe Now!

Bipolar disorder

Bipolar disorder Genetics and mental health Sleep and mental health Aging and mental health

Role of Pediatricians in Diagnosing ADHD

Psychiatric Times

JUNE 23, 2025

Before reaching specialized behavioral health services, families typically consult pediatricians who must possess comprehensive knowledge of ADHD presentation, diagnostic criteria, and evidence-based treatment approaches.

Genetics and mental health

Genetics and mental health Bipolar disorder Sleep and mental health Eating disorders

Prodromal Symptoms of Schizophrenia: Understanding and Addressing Challenges

Psychiatric Times

JUNE 18, 2025

Studies in Australia and the United States followed individuals with subthreshold psychotic symptoms and functional decline, along with a genetic risk for schizophrenia, over time. Research indicates that only 20% to 40% of individuals who meet ultra–high risk (UHR) criteria convert to psychosis within 2 to 4 years.

Genetics and mental health

Genetics and mental health Sleep and mental health Bipolar disorder Early intervention

Criticisms That Establishment Psychiatry Can and Cannot Tolerate

Mad in America

MAY 3, 2025

Establishment psychiatry does acknowledge that emotional suffering and behavioral disturbanceswhat it calls mental illnesseshave biological-psychological-social roots. medical schools. Worldwide, there are parallels to U.S.

Trauma and the brain

Trauma and the brain Aging and mental health Genetics and mental health Bipolar disorder

Are Psychiatrists More Mad Than Their Patients?

Mad in America

MAY 6, 2025

2 Or you are told you have a lack of insight into your disease, which is a symptom of your mental illness, a catch-22 situation from which there is no escape. In 2014, the Danish Ministry of Health issued a licence to kill. Depressive and bipolar disorders: patients attitudes and beliefs towards depression and antidepressants.

Neurotransmitters and mental health

Neurotransmitters and mental health Genetics and mental health Aging and mental health Hospitality

“The New York Times Reruns Familiar ADHD Tropes”

ADDitude

APRIL 16, 2025

April 16, 2025 Every few years, the ADHD community must endure another skeptic an author, a journalist, a contrarian mental health provider, quite frequently a chiropractor recycling claims like “ADHD is overdiagnosed,” “stimulants dont work,” or, most remarkably in one case, “ADHD does not exist.”

Genetics and mental health

Genetics and mental health Aging and mental health Insurance Bipolar disorder

Setting the Record Straight About ADHD and Its Treatments

ADDitude

APRIL 16, 2025

April 16, 2025 Since its publication last Sunday, The New York Times Magazine article “Have We Been Thinking About ADHD All Wrong?” To be clear, identifiable biomarkers do not yet exist for many psychiatric, neurodevelopmental, and neurodegenerative disorders. Or bipolar disorder?” Or anxiety?

Genetics and mental health

Genetics and mental health Aging and mental health Cognitive Behavioral Therapy Hospitality

It's Okay to Need Medication for Mental Health Treatment

Zencare

JANUARY 22, 2025

Published on January 22, 2025 by Zencare Team. There are 298 mental health conditions currently recognized in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition-TR, which is the standard reference for clinical practice among trained, licensed mental health professionals, in the US.

Neurotransmitters and mental health

Neurotransmitters and mental health Sleep and mental health Aging and mental health Genetics and mental health

Mental Health Clinicians

Eyes, Ears, and Emotion: Techniques to Tackle Diagnosing Bipolar Disorder

The Psychiatric Pipeline in Review: Quarter 2, 2025

Trending Sources

FDA Requires New Label Warning of Weight Loss Risk in Pediatric Patients Taking Extended-Release Stimulants for ADHD

NRx Pharmaceuticals Applies for FDA National Priority Voucher for Intravenous Ketamine (NRX-100)

Risk Factors for ADHD

Nonstimulant Therapies for ADHD

ADHD Treatment Options

Role of Pediatricians in Diagnosing ADHD

Prodromal Symptoms of Schizophrenia: Understanding and Addressing Challenges

Criticisms That Establishment Psychiatry Can and Cannot Tolerate

Are Psychiatrists More Mad Than Their Patients?

“The New York Times Reruns Familiar ADHD Tropes”

Setting the Record Straight About ADHD and Its Treatments

It's Okay to Need Medication for Mental Health Treatment

Stay Connected